TITAN BIOTECH
|
|
BOM : 524717     NSE :      | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Oct 10,2024 |
Price(EOD): ₹ 750.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Chemicals |
MCap: ₹ 622.67 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
TITAN BIOTECH | 3% | 26.2% | 106.8% |
PIDILITE INDUSTRIES | -2.2% | -2.9% | 29.3% |
SOLAR INDUSTRIES INDIA | 3.1% | 4.5% | 118.1% |
SRF | -0.3% | -7.7% | 3.9% |
GUJARAT FLUOROCHEMICALS | 14.8% | 18.6% | 54.2% |
DEEPAK NITRITE | -2% | -6.7% | 32.2% |
FUNDAMENTAL ANALYSIS OF TITAN BIOTECH
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF TITAN BIOTECH
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
25.88
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 23.95 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] 4.64
P/B Calculated based on Book Value of Rs 133.56 Cr
[Latest Year - Mar2024 - Consolidated Results ] 3.6
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 172.44 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
239% 260% 446% |
SHARE PRICE MOMENTUM OF TITAN BIOTECH
TITAN BIOTECH vs SENSEX
DEBT OF TITAN BIOTECH
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0.07 0.09 0.13 0.1 |
0.06 0.09 0.21 0.12 |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF TITAN BIOTECH
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF TITAN BIOTECH
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
8.01% 16.54% 17.91% 17.74% |
24.08% 4.6% 6.07% 5.38% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
TITAN BIOTECH related INDICES
You may also like the below Video Courses
FAQ about TITAN BIOTECH
Is TITAN BIOTECH good for long term investment?
As on Oct 10,2024, the Fundamentals of TITAN BIOTECH look Strong and hence it may be good for long term investment! See Financial Performance of TITAN BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is TITAN BIOTECH UnderValued or OverValued?
As on Oct 10,2024, TITAN BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of TITAN BIOTECH ?
As on Oct 10,2024, the Intrinsic Value of TITAN BIOTECH is Rs. 208.65 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 221.31
Fair Value [Median EV / Sales Model] : Rs. 208.65
Fair Value [Median Price / Sales Model] : Rs. 137.28
Estimated Median Fair Value of TITAN BIOTECH : Rs. 208.65
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is TITAN BIOTECH trading at a Premium or Discount?
As on Oct 10,2024, TITAN BIOTECH is trading at a Premium of 260% based on the estimates of Median Intrinsic Value!PIDILITE INDUSTRIES LTD vs SOLAR INDUSTRIES INDIA LTD vs SRF LTD
GUJARAT FLUOROCHEMICALS LTD vs DEEPAK NITRITE LTD vs TATA CHEMICALS LTD